Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: A case series and review of the literature

Journal of Clinical Oncology

Volumn 29, Issue 13, 2011, Pages

  Sohrabi, Sohrab ^a   Drabick, Joseph J ^a   Crist, Henry ^a   Goldenberg, David ^a   Sheehan, Jonas M ^a   Mackley, Heath B ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; SYNAPTOPHYSIN;

ADULT; ADVANCED CANCER; AGED; ANOSMIA; ARTICLE; ARTIFICIAL VENTILATION; BONE NECROSIS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOFACIAL SURGERY; CRANIOTOMY; DERMATITIS; DIPLOPIA; ENDOSCOPY; EPISTAXIS; ESTHESIONEUROBLASTOMA; ETHMOID SINUS; ETHMOIDECTOMY; FEBRILE NEUTROPENIA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; HYPOGEUSIA; IMMUNOHISTOCHEMISTRY; INTENSIVE CARE UNIT; INTUBATION; MALE; MAXILLARY SINUS; MEDICAL RECORD REVIEW; MENINGITIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASAL BIOPSY; NASOPHARYNX; NECK DISSECTION; NECK METASTASIS; NOSE CONGESTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOCEPHALUS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SHOULDER PAIN; SKULL BASE FRACTURE; TUMOR CELL; WEAKNESS; XEROSTOMIA;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESTHESIONEUROBLASTOMA, OLFACTORY; HUMANS; MALE; NEOADJUVANT THERAPY; NOSE NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 79955578101     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.9278     Document Type: Article

References (23)

1. Svane-Knudsen V, Jorgensen KE, Hansen O, et al: Cancer of the nasal cavity and paranasal sinuses: A series of 115 patients. Rhinology 36:12-14, 1998 (Pubitemid 28166207)
2. McCormack LJ, Harris HE: Neurogenic tumors of the nasal fossa. JAMA 157:318-321, 1955
3. Rosenthal DI, Barker JL Jr, El-Naggar AK, et al: Sinonasal malignancies with neuroendocrine differentiation: Patters of failure according to histologic phenotype. Cancer 101:2567-2573, 2004 (Pubitemid 39532286)
4. Polin RS, Sheehan JP, Chenelle AG, et al: The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: The University of Virginia experience. Neurosurgery 42:1029-1037, 1998 (Pubitemid 28196514)
5. Hyams VJ, Batsakis JG, Michaels L: Olfactory neuroblastoma, in Tumors of the Upper Respiratory Tract and Ear. Washington, DC, Armed Forces Institute of Pathology, 1988, pp 240-248
6. Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma: A clinical analysis of 17 cases. Cancer 37:1571-1576, 1976
7. Eich HT, Hero B, Staar S, et al: Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Strahlenther Onkol 179:233-240, 2003 (Pubitemid 36458464)
8. Fitzek MM, Thornton AF, Varvares M, et al: Neuroendocrine tumors of the sinonasal tract: Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 94:2623-2634, 2002 (Pubitemid 34478077)
9. Argiris A, Dutra J, Tseke P, et al: Esthesioneuroblastoma: The Northwestern University Experience. Laryngoscope 113:155-160, 2003 (Pubitemid 36050532)
10. Chao KS, Kaplan C, Simpson JR, et al: Esthesioneuroblastoma: The impact of treatment multimodality. Head Neck 23:749-757, 2001
11. Resto VA, Eisele DW, Forastiere A, et al: Esthesioneuroblastoma: The Johns Hopkins experience. Head Neck 22:550-558, 2000
12. Bhattacharyya N, Thornton AF, Joseph MP, et al: Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Arch Otolaryngol Head Neck Surg 123: 34-40, 1997 (Pubitemid 27043655)
13. Polonowski JM, Brasnu D, Roux FX, et al: Esthesioneuroblastoma: Complete tumor response after induction chemotherapy. Ear Nose Throat J 69:743-746, 1990
14. Mishima Y, Nagasaki E, Terui Y, et al: Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with esthesioneuroblastoma. Cancer 101:1437-1444, 2004 (Pubitemid 39180400)
15. Porter AB, Bernold DM, Giannini C, et al: Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol 90:201-204, 2008
16. Kim DW, Jo YH, Kim JH, et al: Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 101:2257-2260, 2004
17. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998 (Pubitemid 28277960)
18. Dimery IW, Hong WK: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111, 1993 (Pubitemid 23028714)
19. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998 (Pubitemid 28175746)
20. Krstevska V, Stojkovski I, Lukarski D: Concurrent radiochemotherapy in advanced hypopharyngeal cancer. Radiat Oncol 5:39, 2010
21. Kawase A, Nagai K: Treatment strategy for neuroendocrine carcinoma of the lung. Gan To Kagaku Ryoho 36:1619-1622, 2009
22. Hann CL, Rudin CM: Management of small-cell lung cancer: Incremental changes but hope for the future. Oncology (Williston Park) 22:1486-1492, 2008
23. Le QT, Moon J, Redman M, et al: Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. J Clin Oncol 27:3014-3019, 2009